BioTek Synergy™ Neo2 Granted Cisbio HTRF® Certification

BioTek Instruments' new Synergy Neo2 Multi-Mode Reader has received its Cisbio HTRF® certification.

Synergy Neo2 joins several other previously certified readers from BioTek’s current lineup – Cytation™ 5, Cytation 3, Synergy H1 and Synergy 2. Cisbio and BioTek have a long history of collaborative development, most recently in cancer research where the companies' technologies were combined to present an easy-to-use method for assessing target-based and phenotypic effects of new, potential anti-metastatic drugs.

Synergy Neo2 is designed for speed and ultra high performance, incorporating BioTek's patented Hybrid Technology™, with its independent optical paths that ensure uncompromised performance in all detection modes. Continuously variable bandwidth quadruple monochromators, sensitive high transmission filter-based optics, and up to 4 PMTs provide ultra-fast measurements with excellent results.